文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

前列腺癌再放疗后基于影像的复发模式及长期随访

Image-Based Recurrence Patterns After Reirradiation in Prostate Cancer with Long-Term Follow-Up.
PubMed 文献 · Adv Radiat Oncol · 2025-09-16

中位随访99个月,25例生化再复发,20例有充分影像。再复发多位于前列腺内高剂量区内或区内外,约1/3患者伴区域或远处转移。

要点

  • 再放疗后复发多位于前列腺内,高剂量区内及区内外均常见。
  • 约1/3患者再复发时伴区域或远处转移。
  • 无患者仅出现区域或远处转移而无前列腺内复发。

核心结论

  • 前列腺癌再放疗后肿瘤常在前列腺内复发,位于高剂量区内及区内外。
  • 约1/3患者再复发时伴区域或远处转移。

研究设计与样本

  • 复发部位用多参数磁共振成像检查并与剂量分布图比较。

主要发现

  • 中位随访99个月,25例出现生化再复发,20例有充分影像。
  • 5例仅在高剂量区内再复发,7例在高剂量区内和区外均再复发。
  • 2例前列腺复发者接受全腺体立体定向体部放疗而未对肿瘤推量。
  • 4例前列腺内再复发合并区域淋巴结转移,1例前列腺再复发合并单发骨转移,1例前列腺再复发合并淋巴结和骨转移。
  • 无患者仅出现区域或远处转移。

临床怎么用

  • 再放疗后随访应关注前列腺内高剂量区内及区外的复发。
  • 再复发评估需同时排查区域淋巴结和远处转移。

局限性

  • 再放疗技术包括局灶高剂量率近距离放疗和立体定向体部放疗,模式不完全统一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Local failure of prostate cancer after definitive radiation therapy is associated with poor prognosis. Studies on reirradiation have primarily focused on toxicity and oncologic outcome and only partially reported recurrence patterns. Investigating the recurrence pattern may help guide future therapy decisions. METHODS AND MATERIALS: Thirty-three men with local recurrence of prostate cancer after primary definitive radiation therapy were enrolled between 2012 and 2018 (median age 69.8 years [IQR: 6.8], median prostate-specific antigen 4.1 ng/mL [IQR: 3.8]). Twenty-three patients received reirradiation with focal high dose-rate brachytherapy, and 10 received stereotactic body radiation therapy to the prostate with (8/10) or without (2/10) a simultaneous integrated boost to the recurrent tumor. The sites of recurrences were examined with multiparametric magnetic resonance imaging and compared with the dose distribution maps. RESULTS: During the median 99 months (IQR: 56) follow-up, 25 patients had biochemical rerecurrence. Twenty had adequate imaging. Five patients had rerecurrences solely inside the high-dose region, and 7 had both inside and outside the high-dose region. Two patients with a prostatic recurrence received whole-gland stereotactic body radiation therapy without a boost to the tumor. Four had a combination of rerecurrence within the prostate as well as regional lymph node metastases. One patient had a prostatic rerecurrence and a single bone metastasis. One patient had prostatic rerecurrence, lymph node metastases, and bone metastases. No patients had only regional or distant metastases. CONCLUSIONS: After reirradiation of prostate cancer, the tumor frequently recurred within the prostate, both inside and outside the high-dose region. About 1 in 3 patients also had regional or distant metastatic disease at rerecurrence.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Ryg U, Lilleby W, Nilsen LB, et al. Image-Based Recurrence Patterns After Reirradiation in Prostate Cancer with Long-Term Follow-Up. Adv Radiat Oncol. 2025. PMID: 41216207. doi:10.1016/j.adro.2025.101900

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。